1 / 6

Retinal Vein Occlusion Therapeutic Development H1 2015

This report provides comprehensive information on the therapeutic development for Retinal Vein Occlusion, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Retinal Vein Occlusion and special features on late-stage and discontinued projects.

RamonEMarshall01
Download Presentation

Retinal Vein Occlusion Therapeutic Development H1 2015

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. RetinalVein Occlusion - Pipeline Review, H1 2015 By RnRMarketResearch.com Publisher Name : Global Markets Direct Date: 20-May-2015 No. of pages: 106 Single User License: US $2000 Browse more Reports on Ophthalmology Therapeutics at http://www.rnrmarketresearch.com/reports/life-sciences/pharmaceuticals/therapeutics/ophthalmology-therapeutics ©http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441

  2. RetinalVein Occlusion - Pipeline Review, H1 2015 This report gives exhaustive data on the restorative advancement for Retinal Vein Occlusion, complete with similar examination at different stages, therapeutics evaluation by medication target, instrument of activity (MoA), course of organization (RoA) and atom sort, alongside most recent upgrades, and included news and press discharges. It additionally surveys key players included in the helpful advancement for Retinal Vein Occlusion and extraordinary components on late-stage and ceased activities. The report improves choice making capacities and help to make viable counter techniques to increase game changer. It fortifies R&D pipelines by recognizing new targets and MOAs to create first-in-class and best-in-class items. ©http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441

  3. RetinalVein Occlusion - Pipeline Review, H1 2015 Companies Discussed/Mentioned in this Research : Aerpio Therapeutics, Inc., Allergan, Inc., Avalanche Biotechnologies, Inc., F. Hoffmann-La Roche Ltd., Kala Pharmaceuticals, Inc., Mabion SA, NicOx S.A., Ohr Pharmaceutical Inc., pSivida Corp., Regeneron Pharmaceuticals, Inc. and ThromboGenics NV. Drugs Profile Discussed in this Research : aflibercept (recombinant), AKB-9778, AVA-101, beclomethasonedipropionate, fluocinoloneacetonide, loteprednoletabonate, NCX-422, NCX-434, ocriplasmin (recombinant), Peptides to Inhibit Phosphatidylserine for Central Retinal Vein Occlusion, ranibizumab, ranibizumab biosimilar, Recombinant Protein for Central Retinal Vein Occlusion and squalamine lactate. ©http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441

  4. RetinalVein Occlusion - Pipeline Review, H1 2015 Scope For RetinalVein Occlusion - Pipeline Review, H1 2015 • The report provides a snapshot of the global therapeutic landscape of Retinal Vein Occlusion • The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities • The report reviews key players involved in the therapeutics development for Retinal Vein Occlusion and enlists all their major and minor projects • The report summarizes all the dormant and discontinued pipeline projects • A detailed assessment of monotherapy and combination therapy pipeline projects • Coverage of the Retinal Vein Occlusion pipeline on the basis of target, MoA, route of administration and molecule type • Latest news and deals relating related to pipeline products ©http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441

  5. RetinalVein Occlusion - Pipeline Review, H1 2015 Reasons to Buy: • Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage • Develop strategic initiatives by understanding the focus areas of leading companies • Identify and understand important and diverse types of therapeutics under development for Retinal Vein Occlusion • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline • Devise corrective measures for pipeline projects by understanding Retinal Vein Occlusion pipeline depth and focus of Indication therapeutics ©http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441

  6. RetinalVein Occlusion - Pipeline Review, H1 2015 For more details contact Mr. Ritesh Tiwari :sales@rnrmarketresearch.com/ +18883915441 RnRMarkertResearch RnRMarketResearch.com, an online repository of market  research reports, offers in-depth analysis of over 5000 market segments. RnRMarket Research library has syndicated reports by leading market research  publishers across the globe. ©http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441

More Related